CXCL16 and non-small cell lung carcinoma: In the analyzed sera of 40 advanced staged NSCLC patients therapy-induced decrease of CXCL16 levels correlated with prolonged OS compared with patients exhibiting only moderate decrement (Shibata et al., 2020).